In the past few years, we’ve seen headline after headline marveling at the advancements of medical technology. From wearable tech and micro sensors to 3D printing and health-oriented apps, it’s evident that technology and medicine have merged into an industry that’s pushing healthcare to a new level.
Yet many in the health tech industry are also voicing concerns about government regulators and their standards for healthcare technology. Some have even gone as far as accusing the FDA of “stifling” the creativity of healthcare tech and hindering the value these devices and apps could bring to the public.
In early 2014, legislation was introduced in an attempt to redesign the regulatory framework for certain types of technologies and lessen the FDA’s control over this growing industry. But are the FDA’s standards and actions so bad?
I’m in the tech field myself, and while I’ve heard many arguments against the FDA’s regulations, I strongly feel that it’s completely within its rights as a regulatory agency to place limits on medical technology. The FDA’s standards are put in place to protect consumers and to correct disingenuous manufacturer claims — an alarmingly frequent trend in today’s digital world.
The FDA Isn’t the Bad Guy
In the tech world, I often hear “It’s easier to ask for forgiveness later” as an excuse for consciously crossing the line. But when it comes to the medical field, overstepping boundaries could be a matter of life or death.
Too often, companies rush to release new products and technologies to beat competitors or cash in on a trend rather than out of consumer need. Regulations aimed at slowing these companies down to maintain patient safety are completely justified.
With the increased interest in all things health and wellness, we’re seeing more healthcare apps pop up in Apple’s and Google’s app stores. Many apps claim to be able to provide accurate biometric readings using the native tools on smartphones, but buried deep within the fine print (that people don’t read) are explanations that these apps are for “recreational purposes” and are “not FDA-cleared medical devices.”
Apps like these are dangerous and misleading to consumers who might trust their readings.
When it comes to medical safety regulation, the FDA is the most thorough regulatory body in the world. But even it doesn’t have the time and resources to constantly monitor the more than 97,000 healthcare apps that are currently available.
If app manufacturers and regulatory agencies work together to build, approve, and regulate healthcare apps, the entire process could be less burdensome.
How to Improve the Regulation and Approval Process
There are a number of things that both the regulatory agencies and the tech manufacturers can do to improve the tech regulation and approval process overall, including:
- Adhere to preset standards. Medical technology companies can adhere to the standards set by the FDA Safety and Innovation Act when developing products. This will inevitably delay product launches and add expenses, but that’s a reasonable price to pay for the health and safety of consumers.
Additionally, the Office for Civil Rights should verify that medical technology manufacturers are held to HIPAA standards and pinpoint companies that are both good and bad at this.
- Expedite the approval process. The FDA can create a program to help accelerate the review and approval of medical apps — which could include a peer review of new products by healthcare professionals — to attempt to keep pace with today’s innovation.
Since many of these tools help with aspects of preventive care, safe and effective apps should be able to reach consumers quickly.
- Take actions to eliminate dangerous apps. The FDA should make it a priority to get medical apps that aren’t FDA-approved either eliminated from public app stores or clearly relabeled as “for entertainment only.” If actions aren’t taken to better classify apps, consumer health and safety could be seriously jeopardized.
- Grow funding toward research. The NIH and other organizations could increase grants going toward research in medical technology. This would increase funding while allowing these organizations to ensure that research and development follows proper standards and protocols.
While many speak against the FDA’s stifling regulations surrounding healthcare technology, I believe we need regulations to keep dangerous and misleading devices, apps, and manufacturers from harming the public. If the FDA and tech manufacturers would only improve their collaborative efforts, we could reform the regulatory process, produce even more innovative technology, and better educate consumers on the good (and bad) in the healthcare tech world.
Tim Maliyil is the CEO and data security architect for AlertBoot. AlertBoot protects customers from data breaches that damage their credibility, reputation, and business. The company’s managed full disk encryption, email encryption, and mobile security services deploy within minutes to customers’ PCs, smartphones, and tablets, providing tremendous insight, visibility, and control.